LANXESS successfully places EUR 500 million benchmark bond

Cologne

The specialty chemicals company LANXESS has successfully placed a 6-year-tenor euro benchmark bond with a coupon of 0.0 percent in the European capital market. LANXESS will use the funds to finance the planned acquisition of the microbial control business of US-based chemical company IFF.

The new bond is listed on the Luxembourg Stock Exchange in denominations of EUR 1,000.

“We have secured a first step of financing already quickly after the announcement of the acquisition of IFF Microbial Control and are happy about the very receptive reaction of the capital market to our offering,” said LANXESS Chief Financial Officer Michael Pontzen.

LANXESS' issuer ratings are currently Baa2 (Moody’s), BBB (Standard & Poor’s) and BBB+ (Scope). A bank consortium of active joint bookrunners comprising Citi, Société Générale and Unicredit was mandated to place the bond.

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

PRESS RELEASE
Wear on gears on gear stress test rig (FZG)

Sustainable lubricant additive for extreme pressure applications

October 30, 2025
PRESS RELEASE
production plant O10 Leverkusen Saltigo reactors

Saltigo at CPHI 2025: Europe`s Reliable CDMO Partner with a Broad Technology Portfolio

October 22, 2025
PRESS RELEASE
Home Care, Household Care, Cleaning agents,

LANXESS at the SEPAWA Congress 2025: Innovations for household and personal care products

October 07, 2025
PRESS RELEASE
Logo K 2025 mit Datum

LANXESS at K 2025: Focus on additives, colorants and pigments

October 03, 2025
PRESS RELEASE
Sustainability.

LANXESS reduces CO₂ footprint for products at Botlek site

September 17, 2025